Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.38 - $0.64 $50,204 - $84,554
-132,117 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.55 - $0.98 $8,023 - $14,297
-14,589 Reduced 9.94%
132,117 $88,000
Q4 2021

Feb 11, 2022

BUY
$0.9 - $1.31 $6,536 - $9,514
7,263 Added 5.21%
146,706 $144,000
Q3 2021

Nov 04, 2021

SELL
$1.21 - $1.61 $7,189 - $9,566
-5,942 Reduced 4.09%
139,443 $179,000
Q2 2021

Aug 11, 2021

SELL
$1.6 - $2.02 $7,100 - $8,964
-4,438 Reduced 2.96%
145,385 $237,000
Q1 2021

May 13, 2021

SELL
$1.86 - $2.87 $18,661 - $28,794
-10,033 Reduced 6.28%
149,823 $296,000
Q4 2020

Feb 16, 2021

BUY
$1.65 - $2.43 $71,784 - $105,719
43,506 Added 37.39%
159,856 $330,000
Q3 2020

Nov 12, 2020

SELL
$1.6 - $2.35 $6,752 - $9,917
-4,220 Reduced 3.5%
116,350 $199,000
Q2 2020

Aug 13, 2020

BUY
$1.33 - $2.76 $160,358 - $332,773
120,570 New
120,570 $280,000
Q4 2019

Feb 14, 2020

SELL
$1.69 - $3.8 $1,825 - $4,104
-1,080 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$0.61 - $2.21 $305,383 - $1.11 Million
-500,629 Reduced 99.78%
1,080 $1,000
Q2 2019

Aug 14, 2019

BUY
$0.51 - $0.86 $53,486 - $90,193
104,876 Added 26.43%
501,709 $326,000
Q1 2019

May 15, 2019

SELL
$0.51 - $0.82 $226,408 - $364,029
-443,939 Reduced 52.8%
396,833 $247,000
Q4 2018

Feb 14, 2019

BUY
$0.48 - $1.1 $44,761 - $102,579
93,254 Added 12.48%
840,772 $405,000
Q3 2018

Dec 21, 2021

BUY
$1.06 - $1.69 $43,771 - $69,786
41,294 Added 5.85%
747,518 $822,000
Q3 2018

Nov 14, 2018

BUY
$1.06 - $1.69 $252,446 - $402,485
238,157 Added 50.88%
706,224 $776,000
Q2 2018

Apr 21, 2020

BUY
$1.56 - $2.51 $79,371 - $127,706
50,879 Added 12.2%
468,067 $730,000
Q2 2018

Aug 14, 2018

BUY
$1.56 - $2.51 $303,722 - $488,681
194,694 Added 87.51%
417,188 $650,000
Q1 2018

Oct 18, 2019

BUY
$0.91 - $2.24 $30,739 - $75,667
33,780 Added 17.9%
222,494 $474,000
Q1 2018

May 15, 2018

SELL
$0.91 - $2.24 $145,756 - $358,785
-160,172 Reduced 45.91%
188,714 $402,000
Q4 2017

Feb 14, 2018

SELL
$0.78 - $2.1 $314,722 - $847,329
-403,490 Reduced 53.63%
348,886 $320,000
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $1.17 Million - $1.37 Million
752,376
752,376 $1.33 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $216M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.